Apr 27, 2022
Do you know the eligibility criteria for CAR T-cell therapy in relapsed/refractory (R/R) multiple myeloma (MM); did you know that there is no age limit for patients?
Credit available for this activity expires: 4/26/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972593?src=mkm_podcast_addon_972593